BioAdaptives Inc. (OTCMKTS:BDPT) All Set to Launch Advanced Next Generation Products for Natural Health Practitioners
BioAdaptives Inc. (OTCMKTS:BDPT) formulates dietary supplements that are carefully selected from the best worldwide sources and utilize proprietary methods of boosting the bioavailability of nutrients. It also manufactures and distributes plant- and algal-based products, aimed at enhancing health and wellness for humans and animals. The focus is to optimize pain relief, anti-viral activity and immune system defense, resistance to stress, endurance, recovery from injury, illness and exercise, and anti-aging properties.
Market Stats
On Thursday, BDPT stock moved down 20.51% to $0.0031 with 38.54 million shares, compared to its average volume of 1.61 million shares. The stock moved within a range of $0.0030 – 0.0057 after opening trading at $0.0044.
BioAdaptives, Inc. Launching Next Generation Products for Natural Health Practitioners
BioAdaptives, Inc. is all set to launch an enhanced, next generation product line for holistic healthcare practitioners. These are more advanced versions of proven existing nutraceuticals, due to modifications in ingredients, dose and/or composition. The U.S. market for alternative care goods and services was valued at approximately $21b in 2021, and the providers include over one million U.S.-based physical and massage therapists, naturopathic physicians, acupuncturists, chiropractors and other holistic health practitioners.
The company will continue offering present consumer products to retail customers on-line, which includes PluriPain, PrimiSleep, PrimiLungs and PrimiCell, along with a soon-to-be-introduced nootropic, PluriMind. For holistic healthcare practitioners, it will offer “Nu” branded products with enhanced functions in these same areas.
The new, anti-stress, all-natural product, PrimiSleep, was launched in the first week of July 2022. It is aimed towards inducing relaxation and restful, continuous sleep. Comprehensively developed and test-marketed, this advanced formulation is based on Traditional Chinese Medicine and Ayurvedic Culture. It is in response to a growing demand for an effective natural sleep aid without the “hangover” effect, which is common with most supplements.
A prominent feature of PrimiSleep is that, unlike most pharmaceuticals, is that cognitive ability won’t be compromised, in the event of untimely awakening or difficulty in the process of returning to sleep. It is specifically formulated with balanced ingredients to replenish energy and vitality. Clinical studies show that components of PrimiSleep promote a restorative sleep pattern with increased REM intervals known to be beneficial. The supplement is all-natural, does not contain pharmaceuticals, and has no reported adverse reactions or dependence concerns.
Dr. Edward Jacobs, BioAdaptives’ CEO, has said that the “Nu” brand products are practitioner-level and intended for use by holistic practitioners and alternative healthcare providers for targeting clients’ debilitating symptoms. They include brain fog, fatigue and sleep disturbances that are both poorly understood and often associated with the aftermath of COVID-19 infections. The symptoms are challenging for patients and the professionals who want to help manage their clients’ health needs.
Moreover, professionals are finding success in utilizing BioAdaptives’ products because they contain ingredients that are known to have neuro-protective, anti-viral, anti-inflammatory and antioxidant properties. The company also adopts a holistic approach, so the products are reported to improve moods and induce a calming effect.
Key Quote
Dr. Edward Jacobs, BioAdaptives’ CEO, stated, “The “Nu” brand products are practitioner-level and intended for use by holistic practitioners and alternative healthcare providers in targeting their clients’ debilitating symptoms, including brain fog, fatigue and sleep disturbances that are both poorly understood and frequently associated with the aftermath of COVID-19 infections. These symptoms are challenging for patients and the professionals who want to help manage their clients’ health needs. Increasingly, professionals are finding success in utilizing our products because they contain ingredients that are known to have neuro-protective, anti-viral, anti-inflammatory and antioxidant properties. Furthermore, as part of a holistic approach, our products are reported to elevate mood and promote a calming effect.”
Traders Corner
BDPT stock is trading below the 20-Day and 50-Day Moving averages of $0.0043 and $0.0049 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0111.
